| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $5,575,274 ) |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R03DE034789 | PDGFRbeta-mediated skeletal-vascular crosstalk in calvarial bone marrow development | 000 | 1 | NIH | 2/13/2026 | $341,000 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL163095 | Novel lymphatic genes that regulate heart valve development and disease | 000 | 4 | NIH | 1/30/2026 | $507,628 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01EY034946 | Retinal Pigmented Epithelium Epigenome Dysregulation With Aging and Modulation by Diet | 000 | 3 | NIH | 1/29/2026 | $531,146 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DE032911 | Aging and Oxidative Stress Influence Salivary Gland Disease in Sjogren's Syndrome | 000 | 4 | NIH | 1/27/2026 | $457,898 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01NS135830 | Influence of neuromelanin on single dopaminergic neurons in Parkinson's disease. | 000 | 2 | NIH | 1/23/2026 | $538,719 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DA062881 | Cell type-specific neurotensin signaling in methamphetamine use disorder | 000 | 1 | NIH | 2/6/2026 | $648,389 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM152165 | Centromere behaviors that promote proper chromosome segregation in meiosis and mitosis | 000 | 3 | NIH | 12/16/2025 | $383,625 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AR080896 | PDGFRB Signaling in Progressive Skin Disease | 000 | 4 | NIH | 1/22/2026 | $476,629 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074502 | Determining the context specificity of metformin treatment on muscle mitochondria and healthspan | 000 | 5 | NIH | 1/28/2026 | $530,077 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG081855 | Mitochondrial NAD+ Metabolism in Cardiac Aging | 000 | 3 | NIH | 1/26/2026 | $538,367 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI168355 | Complement C5 inhibition as sepsis therapy | 000 | 5 | NIH | 1/26/2026 | $633,416 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | K99AG086524 | Investigating TFEB as a critical node to improve proteostatic maintenance and skeletal muscle function with age | 000 | 2 | NIH | 12/10/2025 | $135,057 |
| | 2026 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35HL145237 | Translational Control of Megakaryocyte and Platelet Gene Expression in Disease | 000 | 7 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21AI194204 | Notch regulation of airway epithelial-immune cell cross-talk in SARS-CoV-2 infection | 000 | 1 | NIH | 2/6/2026 | $0 |
| | 2026 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P20GM139763 | Center for Cellular Metabolism Research in Oklahoma | 001 | 5 | NIH | 12/5/2025 | $0 |
| | 2026 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P20GM139763 | Center for Cellular Metabolism Research in Oklahoma | 000 | 5 | NIH | 11/20/2025 | $0 |
| | 2026 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM137921 | Molecular and cellular mechanisms regulating mitochondrial subpopulation dynamics and function in vivo | 000 | 5 | NIH | 1/20/2026 | $0 |
| | 2026 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | DP5OD033443 | Sex chromosomal regulation of hippocampal microglial activation with Alzheimer's disease and aging | 000 | 3 | NIH | 1/28/2026 | $0 |
| | 2026 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL149860 | Platelet CLEC-2 in Arterial Thrombosis | 000 | 4 | NIH | 12/23/2025 | $0 |
| | 2026 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DE028001 | Sjogren's Syndrome Pathogenic Autoantibodies | 000 | 5 | NIH | 2/10/2026 | -$7,118 |
| | 2026 | 2022 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P20GM103636 | Expanding Excellence in Developmental Biology in Oklahoma | 000 | 10 | NIH | 1/14/2026 | -$125,523 |
| | 2026 | 2022 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | CE146576 | Community Project Funding/Congressionally Directed Spending - Construction | 07 | 1 | HRSA | 1/23/2026 | -$14,036 |
|
| Issue Date FY: 2025 ( Subtotal = $44,625,510 ) (Continued on the next page) |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21AR084235 | MuRF1 substrates and mechanisms of skeletal muscle atrophy | 001 | 2 | NIH | 4/29/2025 | $13,129 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21AR084235 | MuRF1 substrates and mechanisms of skeletal muscle atrophy | 000 | 2 | NIH | 3/3/2025 | $168,795 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL101917 | Protease Activated Receptor and Thrombomodulin Signaling by coagulation proteases | 001 | 15 | NIH | 7/18/2025 | $426,250 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21AG085486 | The role of tetraspanin-regulated endolysosomal trafficking in Alzheimer's Disease | 000 | 2 | NIH | 6/26/2025 | $195,938 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AR080896 | PDGFRB Signaling in Progressive Skin Disease | 001 | 3 | NIH | 5/9/2025 | $37,071 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AR080896 | PDGFRB Signaling in Progressive Skin Disease | 000 | 3 | NIH | 1/23/2025 | $476,629 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21HL175092 | Multi-Omic Characterization of Immune Cells in Sarcoidosis | 000 | 2 | NIH | 8/15/2025 | $127,875 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UM1AI144292 | Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success | 001 | 7 | NIH | 5/6/2025 | $767,250 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UM1AI144292 | Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success | 002 | 7 | NIH | 8/6/2025 | $400,579 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM152165 | Centromere behaviors that promote proper chromosome segregation in meiosis and mitosis | 002 | 2 | NIH | 8/12/2025 | $42,625 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM152165 | Centromere behaviors that promote proper chromosome segregation in meiosis and mitosis | 001 | 2 | NIH | 12/10/2024 | $383,625 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI168355 | Complement C5 inhibition as sepsis therapy | 000 | 4 | NIH | 3/21/2025 | $633,416 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 007 | 4 | NIH | 9/16/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 004 | 4 | NIH | 6/13/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 007 | 4 | NIH | 9/16/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 4 | NIH | 6/13/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 4 | NIH | 3/24/2025 | $100,000 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 007 | 4 | NIH | 9/16/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 4 | NIH | 6/13/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 4 | NIH | 3/24/2025 | $1 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 007 | 4 | NIH | 9/16/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 003 | 4 | NIH | 6/13/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 4 | NIH | 3/24/2025 | $150,000 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 006 | 4 | NIH | 9/15/2025 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 002 | 4 | NIH | 3/31/2025 | $1 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 005 | 4 | NIH | 8/26/2025 | $250,000 |
|
